Rhumbline Advisers Antares Pharma, Inc. Transaction History

Rhumbline Advisers

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	N/A	-188,475 Closed	0 $0
Q1 2022 May 12, 2022	SELL	N/A	-138 Reduced 0.07%	188,475 $773,000
Q4 2021 Feb 10, 2022	SELL	N/A	-71,322 Reduced 27.44%	188,613 $673,000
Q3 2021 Nov 12, 2021	SELL	N/A	-24,719 Reduced 8.68%	259,935 $946,000
Q2 2021 Aug 05, 2021	BUY	N/A	17,518 Added 6.56%	284,654 $1.24 Million
Q1 2021 May 06, 2021	SELL	N/A	-13,680 Reduced 4.87%	267,136 $1.1 Million
Q4 2020 Feb 10, 2021	BUY	N/A	19,855 Added 7.61%	280,816 $1.12 Million
Q3 2020 Nov 12, 2020	SELL	N/A	-17,780 Reduced 6.38%	260,961 $705,000
Q2 2020 Aug 13, 2020	BUY	N/A	57,091 Added 25.76%	278,741 $767,000
Q1 2020 May 06, 2020	SELL	N/A	-1,100 Reduced 0.49%	221,650 $523,000
Q4 2019 Feb 05, 2020	BUY	N/A	9,304 Added 4.36%	222,750 $1.05 Million
Q3 2019 Oct 23, 2019	SELL	N/A	-1,575 Reduced 0.73%	213,446 $714,000
Q2 2019 Aug 14, 2019	BUY	N/A	31,316 Added 17.05%	215,021 $707,000
Q1 2019 May 01, 2019	SELL	N/A	-3,158 Reduced 1.69%	183,705 $557,000
Q4 2018 Jan 31, 2019	BUY	N/A	62,857 Added 50.69%	186,863 $508,000
Q3 2018 Nov 07, 2018	SELL	N/A	-9,235 Reduced 6.93%	124,006 $417,000
Q2 2018 Aug 06, 2018	BUY	N/A	10,425 Added 8.49%	133,241 $344,000
Q1 2018 May 02, 2018	SELL	N/A	-1,800 Reduced 1.44%	122,816 $270,000
Q4 2017 Feb 09, 2018	SELL	N/A	-25,672 Reduced 17.08%	124,616 $248,000
Q3 2017 Nov 06, 2017	BUY	N/A	150,288	150,288 $487,000

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.